Skip to main content
NCBI home page
Springer logoLink to Springer
. 2025 Jul 25;33(8):4651–4658. doi: 10.1007/s10787-025-01868-x

Is dolichol pathway dysfunction a significant factor in Alzheimer’s disease?

John V Schloss 1,✉
PMCID: PMC12397121  PMID: 40715929

Abstract

Several lines of evidence point to defects in the dolichol pathway as a major contributor to the development of Alzheimer’s disease and inflammation associated with the unfolded protein response. In particular, zinc deficiency impairs formation of dolichol phosphate and low levels of pyridine nucleotides (NAD or NADPH), due to niacin deficiency, result in reduced conversion of polyprenol to dolichol phosphate, leading to reduced N-glycosylation of proteins. The magnesium-dependent transfer of N-acetyl-d-glucosamine-1-phosphate between dolichol phosphate (necessary for N-glycosylation) and UMP (required for O-glycosylation) by DPAGT1 ties dolichol phosphate biosynthesis to the balance between O- and N-glycosylation. Alteration of protein glycosylation would affect the folding, function, and physical properties (e.g., solubility) of many glycoproteins, such as UDP-glucuronosyltransferase (anosmia), amyloid precursor protein, tau, acetylcholine receptors, ligand-gated ion channels, voltage-gated ion channels, and G protein-coupled receptors. Three of the five best documented stress-induced nutritional deficiencies (i.e., zinc, niacin, and magnesium) would contribute to alterations in glycosylation of these and many other proteins involved in the progression of Alzheimer’s disease.

Keywords: N- and O-glycosylation, Dolichol phosphate, Zinc, Magnesium, Niacin, Alzheimer’s disease

Introduction: zinc and Alzheimer’s disease

Alzheimer’s disease (AD) is one of the most common forms of incurable, progressive senile dementia, with a complex pathophysiology featuring brain inflammatory processes (Twarowski and Herbet 2023). An early indication of AD is loss of the sense of smell (Doty 2019). Anosmia is also an early indicator for COVID-19 (Amadoro et al. 2023). SARS‑CoV‑2 infection morbidity, mortality, and impaired humoral response correlate with a deficiency in free zinc, distinct from most zinc, which is an integral, tightly bound part of proteins (Heller et al. 2021; Chillon et al. 2022). Zinc deficiency, induced by viral infection, is a likely cause of anosmia associated with acute SARS-CoV-2 infections and Long COVID (Schloss 2023). Post-COVID, the survivors are at substantially higher risk of developing AD (Aleman et al. 2025). SARS-CoV-2 infection and AD seem to share zinc deficiency, manifest as anosmia, as an early indicator of disease and an underlying contributing factor to disease progression. Zinc dietary supplements seem to benefit patients who have AD (Rivers-Auty et al. 2021). The basis for Zn2+-deficiency-induced anosmia can be linked to the dolichol pathway (Fig. 1). An enzyme essential to olfaction, UDP-glucuronosyltransferase (e.g., UGT2A1), requires N-glycosylation and has been linked to anosmia associated with COVID-19 and zinc deficiency (Neiers et al. 2021; Shelton et al. 2022; Schloss 2023). Deficiencies in pyridine nucleotides (derived from niacin) and zinc, both essential to proper functioning of the dolichol pathway, can result directly from infections or due to stress related to the pandemic and its aftermath (Schloss 2023; Lopresti 2020).

Fig. 1.

Fig. 1

Open in a new tab

The biosynthetic pathway for dolichol phosphate

Congenital disorders of glycosylation

How can levels of free zinc impact the progression of AD? AD patients have even higher levels of dolichol in their brains than the increases normally associated with aging (Wolfe et al. 1985; Bergamini et al. 2004). Paradoxically, polyprenol precursors to dolichol improve cognition in AD animal models and in preliminary clinical trials (Fedotova et al. 2016a, b; Soultanov et al. 2017; Fedotova et al. 2016a, b; Fedotova et al. 2012, 2010). A possible explanation for this paradox involves the dolichol kinase (DOLK). DOLK requires free zinc and CTP to phosphorylate dolichol (Sakakihara and Volpe 1985). Expression of DOLK is highest in the human brain, during fetal development and in the adult, indicating an important role for DOLK in the central nervous system (Farooqi et al. 2023). Only the brain DOLK is selective for zinc, since the enzyme in other tissues is less restrictive in its metal requirement. Mutations that reduce the levels of DOLK or polyprenol dehydrogenase/reductase (SRD5A3 and DHRSX) result in congenital disorders of glycosylation (CDG) (Wilson et al. 2024; Paprocka et al. 2021). CDG is manifested, in part, by devastating intellectual disability and other neurological problems. Among the glycosylated proteins affected by CDG are the amyloid precursor protein (APP), tau protein, and voltage-gated calcium channels (Schedin-Weiss et al. 2014; Lazniewska and Weiss 2017). Glycosylation disorders correlate with the development of AD.

Zinc deficiency: multiple mechanisms of pathophysiology, oxidative stress and inflammation

Zinc is known to regulate the transcription factor nuclear factor erythroid 2-related factor 2, known as Nrf2 (Vali et al. 2025). The Nrf2 pathway modulates oxidative stress and regulates antioxidant defenses, which is critical in the pathogenesis of neurological diseases. The Kelch-like ECH-associated protein 1, known as Keap1, regulates Nrf2 by facilitating its ubiquitination and proteolysis (Song et al. 2024). Together, the Nrf2–Keap1 axis regulates oxidative stress and inflammation. Both Keap1 and Nrf2 are subject to O-GlcNAcylation that affects their activity-dependent protein folding and can prevent phosphorylation-dependent inactivation of Nrf2 by kinases. There are only two enzymes that either glycosylate (O-GlcNAcylation, O-GlcNAc transferase, OGT) Keap1 (Ser104, Chen et al. 2017) or Nrf2 (Ser103, Zhang et al. 2024) or remove carbohydrates from either enzyme (O-GlcNAcase, OGA). The Keap1–Nrf2 axis is intimately interrelated with the inflammatory signaling pathway primarily governed by nuclear factor-kappa B (NF-κB). While Nrf2 activation is generally anti-inflammatory, NF-κB activation is pro-inflammatory (Gao et al. 2022). Like Keap1 and Nrf2, NF-κB is also regulated by O-GlcNAcylation (Liu and Ramakrishnan 2021). Glycosylation of NF-κB regulates cancer cell proliferation, survival, and metastasis, providing a nutrient-dependent link between inflammation and cancer. Although Nrf2, Keap1, and NF-κB are subject to O-glycosylation, they are not directly modified by zinc- and dolichol phosphate-dependent N-glycosylation.

The regulation of the Nrf2–Keap1 axis by zinc is thought to involve direct interaction of Zn2+ with Keap1 (McMahon et al. 2018). However, zinc deficiency may have other, indirect effects on Nrf2–Keap1, O-glycosylation, oxidative stress, and inflammation, through the magnesium-dependent dolichyl-phosphate N-acetylglucosaminephosphotransferase (DAPGT1)-mediated link between N- and O-glycosylation (Fig. 2). Transfer of N-acetylglucosamine-1-phosphate from UDP-N-acetyl-d-glucosamine to dolichol phosphate produces N-acetyl-d-glucosaminyl-diphosphodolichol, which is essential for N-glycosylation (Fig. 2). Reducing the flux between N- and O-glycosylation pathways by zinc-limited production of dolichol phosphate or magnesium-limited reduction of DAPGT1 activity could result in alteration of N- and O-glycosylation patterns with resultant pathology. Support for this proposition comes from the inhibition of DAPGT1 by tunicamycin (Yoon et al. 2023). Tunicamycin is used as an antibiotic and anticancer drug. It inhibits N-linked glycoprotein synthesis by inhibition of DAPGT1, leading to the accumulation of misfolded proteins in the endoplasmic reticulum (ER), producing ER stress, oxidative stress, and inflammation. This process is associated with activation of the unfolded protein response (UPR) pathways (Fig. 3) modulating reactive oxygen species (ROS) generation, reduced glutathione (GSH) metabolism, and various inflammatory signaling cascades in the brain (Sita et al. 2023; Hoozemans et al. 2006). The disruption of UDP-glucuronosyltransferase N-glycosylation and the UPR in the olfactory system also explains why anosmia is an early indicator of Alzheimer’s disease (Nakajima et al. 2010; Murray et al. 2020; Tong et al. 2017).

Fig. 2.

Fig. 2

Open in a new tab

Interconnection between O- and N-glycosylations

Fig. 3.

Fig. 3

Open in a new tab

Stress-induced blockage of N-glycosylation

Other aspects of the pathophysiology associated with zinc deficiency can be attributed to its use as an essential component in the active sites of various enzymes (Portbury and Adlard 2017), such as metalloproteases like angiotensin converting enzyme (Ekmekci et al. 2003) or alcohol dehydrogenases like retinol dehydrogenase (Yin et al. 2003), or as essential structural components in 8–10% of all proteins (Andreini et al. 2006), such as the zinc-fingers of DNA binding proteins (Neuhaus 2022).

N-glycosylated proteins associated with Alzheimer’s disease and alteration of the N- to O-glycosylation ratio

Paradoxically, if the rate of N-glycosylation in the ER is slowed for proteins that have multiple N- and O-glycosylation sites, then the protein may be misfolded between early and late N-glycosylation events. This could lead to retention of the misfolded protein in the ER and premature termination of further N-glycosylation, preventing migration of the protein out of the ER into the cytoplasm, and prevent later O-glycosylation. This premature termination of both N- and O-glycosylation after an early N-glycosylation event would be interpreted as over N-glycosylation at the expense of O-glycosylation, which has been observed (Kang et al. 2024). Various proteins that are N-glycosylated, associated with AD, and would contribute to disease progression include: amyloid precursor protein (Lin et al. 2022), voltage-gated ion channels (e.g., potassium channels Kv1.3, Kv1.4, and HERG) (Gong et al. 2002; Watanabe et al. 2004; Zhu et al. 2012), calcium channels (e.g., Cav3.2) (Weiss et al. 2013; Scott and Panin 2014), voltage-gated calcium channels (Lazniewska and Weiss 2017), nicotinic acetylcholine receptors (Wanamaker and Green 2005; Nishizaki 2003), muscarinic receptors (Romero-Fernandez et al. 2011), G protein-coupled receptors (Christoffer et al. 2020), metabotropic glutamate receptors (Miller et al. 2024), ionotropic glutamate receptors (Lichnerova et al. 2015), AMPA receptors (Kandel et al. 2018), dopamine receptors (Min et al. 2015), serotonin receptors (Maginnis et al. 2010), and tau protein (Mathew et al. 2023), although this is not meant to be a comprehensive list. Phosphorylated tau (pTau217) is a marker for AD that responds to oral supplementation of nicotinamide riboside, which raises pyridine nucleoside levels necessary for dolichol pathway function (Devanarayan et al. 2024; Wu et al. 2025). Premature termination of tau N-glycosylation and retention of tau in the endoplasmic reticulum without O-glycosylation in the cytoplasm could lead to increased levels of phosphorylated tau.

Stress, nutritional deficiencies, and AD

Stress is considered to be a major risk factor for the development of AD (Lyons and Bartolomucci 2020). Considerable evidence exists that stress induces deficiencies in magnesium, zinc, calcium, iron, and niacin (Lopresti 2020). Of these five well-documented, stress-induced micronutrient deficiencies, three, zinc, niacin, and magnesium, are involved in the early essential steps of N-glycosylation (Figs. 1, 2). Clearly, deficiencies in one or more of these micronutrients would reduce the rate of biosynthetic steps dependent on DPAGT1 (magnesium dependent; Mg2+ is known to be neuroprotective, Patel et al. 2024), DOLK (free Zn2+ dependent), DHRSX (NAD or NADP dependent), or SRD5A3 (NADPH dependent). It is unusual to have both NAD (catabolic) and NADPH (anabolic) pyridine nucleotides involved in the same biosynthetic pathway (Wilson et al. 2024; Fessel and Oldham 2018). This requirement is thought to facilitate essential oxidation of polyprenol by physiological concentrations of NAD (predominantly in the oxidized form) followed by reduction of polyprenal and dolichal by NADPH (predominantly in the reduced form) to dolichol (Wilson et al. 2024). Other metal ions only partially support brain DOLK activity relative to free zinc ions and at non-physiological concentrations (Sakakihara and Volpe 1985). Other circumstantial evidence implicating dolichol pathway dysfunction in AD is the beneficial effect nutritional supplements have on Alzheimer’s disease that raise levels of NAD/NADPH or CTP (Wuerch et al. 2023; Bonvicini et al. 2023). Citicoline would not only raise choline and acetylcholine levels to improve neurotransmission but would also raise CTP levels required for DOLK (Shridas and Waechter 2006). Although lower NADPH levels would lead to diminished reduced glutathione and enhanced oxidative stress, pyridine nucleotides are also required for conversion of polyprenol to dolichol by DHRSX (NAD/NADH) and SRD5A3 (NADPH) (Wilson et al. 2024). Although the brains of individuals with Alzheimer’s disease have higher levels of glucose 6-phosphate dehydrogenase (G6PD), this may be a compensatory response to lower total levels of pyridine nucleotides to increase NADPH and GSH production (Russell et al. 1999). Overexpression of G6PD in a mouse model of Alzheimer’s disease increases NADPH, which is needed for both dolichol and GSH biosynthesis, and rescues loss of cognition (Correas et al. 2024). Also, the higher risk women have of niacin deficiency due to estrogen-impaired biosynthesis could explain the higher frequency of AD in women (Bender and Totoe 1984; Lopez-Lee et al. 2024). Women are reported to have lower levels (9.3% less), on average, of whole blood NAD (31.3 micromolar) compared to the levels in men (34.5 micromolar) (Yang et al. 2022). African Americans are 1.5–2 times more likely to develop AD than other ethnic groups, perhaps as a consequence of higher stress levels in this group (Lennon et al. 2022). There is also a much higher risk for AD and infection burden in homeless populations (Babulal et al. 2022; Beydoun et al. 2024), where stress and nutritional deficiencies are likely to play a major role. Stress-induced aging is a risk factor for all populations (Polsky et al. 2022), with aging-associated risk for loss of the sense of smell (Dong et al. 2017) and development of AD (Liu 2022).

Based on a lymphocyte proliferation assay, the general incidence of deficiencies in zinc (33%), magnesium (18%), and niacinamide (13%) is prevalent and consistent with their identification as three of the five best-documented, stress-induced nutritional defects (Bucci 1994; Lopresti 2020). Up to 25% of Americans are concurrently deficient in five or more essential nutrients, as judged by a lymphocyte proliferation assay (Bucci 1994). The fact that there are multiple biosynthetic steps tied to stress means their combined effect should produce an overall greater risk than any one alone. Depression of each step by 50% for the five steps of N-acetyl-d-glucosaminyl-diphosphodolichol biosynthesis (niacin, zinc, and magnesium dependent) could reduce the overall rate of N-glycosylation by up to 97%. Clearly, small depressions in these essential stress-affected nutrients can be amplified to have devastating consequences.

Summary

A preponderance of available literature indicates that stress-related depression of cofactors necessary for the dolichol pathway (pyridine nucleotides, zinc, and magnesium) is a major risk factor for the development and progression of Alzheimer’s disease.

Abbreviations

HRSX

Polyprenol dehydrogenase/reductase X-linked

SRD5A3

Steroid 5-alpha-(polyprenol)-reductase 3

DOLK

Dolichol kinase

AD

Alzheimer’s disease

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2

COVID

Coronavirus disease 2019

Long COVID

Post COVID-19 condition

UDP

Uridine diphosphate

CTP.

Cytidine triphosphate

CDG

Congenital disorders of glycosylation

APP

Amyloid precursor protein

Nrf2

Nuclear factor erythroid 2-related factor 2

Keap1

Kelch-like ECH-associated protein 1

GlcNA

N-Acetyl-d-glucosamine

OGT

O-Linked N-acetylglucosaminyltransferase

OGA

(Protein)-3-O-(N-acetyl-d-glucosaminyl)-l-serine/threonine N-acetylglucosaminyl hydrolase

NF-κB

Nuclear Factor-kappa B

DAPGT1

UDP-N-acetylglucosamine—dolichyl-phosphate N-acetylglucosaminephosphotransferase

UPR

Unfolded protein response

GSH

Reduced glutathione

ER

Endoplasmic reticulum

NAD

Nicotinamide adenine dinucleotide

NADPH

Reduced nicotinamide adenine dinucleotide phosphate

Funding

The author declares that no funds, grants, or other support were received during the preparation of this manuscript.

Data availability

There is no original data to be shared in this manuscript.

Declarations

Competing interests

The author has no relevant financial or non-financial interests to disclose.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Aleman GG, Vavougios GD, Tartaglia C, Uvais NA, Guekht A, Hosseini AA, Lo Re V, Ferreccio C, D’Avossa G, Zamponi HP, Figueredo Aguiar M, Yecora A, Ul Haq Katshu MZ, Stavrou VT, Boutlas S, Gourgoulianis KI, Botero C, González Insúa F, Perez-Lloret S, Zinchuk M, Gersamija A, Popova S, Bryzgalova Y, Sviatskaya E, Russelli G, Avorio F, Wang S, Edison P, Niimi Y, Sohrabi HR, Mukaetova Ladinska EB, Neidre D, de Erausquin GA (2025) Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infection. Front Aging Neurosci 16:1432357. 10.3389/fnagi.2024.1432357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amadoro G, Latina V, Stigliano E, Micera A (2023) COVID-19 and Alzheimer’s disease share common neurological and ophthalmological manifestations: a bidirectional risk in the post-pandemic future. Cells 12(22):2601. 10.3390/cells12222601 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andreini C, Banci L, Bertini I, Rosato A (2006) Zinc through the three domains of life. J Proteome Res 5(11):3173–3178. 10.1021/pr0603699 [DOI] [PubMed] [Google Scholar]
  4. Babulal GM, Rani R, Adkins-Jackson P, Pearson AC, Williams MM (2022) Associations between homelessness and Alzheimer’s disease and related dementia: a systematic review. J Appl Gerontol 41(11):2404–2413. 10.1177/07334648221109747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bender DA, Totoe L (1984) Inhibition of tryptophan metabolism by oestrogens in the rat: a factor in the aetiology of pellagra. Br J Nutr 51(2):219–224. 10.1079/bjn19840026 [DOI] [PubMed] [Google Scholar]
  6. Bergamini E, Bizzarri R, Cavallini G, Cerbai B, Chiellini E, Donati A, Gori Z, Manfrini A, Parentini I, Signori F, Tamburini I (2004) Ageing and oxidative stress: a role for dolichol in the antioxidant machinery of cell membranes? J Alzheimers Dis 6(2):129–135. 10.3233/jad-2004-6204 [DOI] [PubMed] [Google Scholar]
  7. Beydoun MA, Beydoun HA, Hedges DW, Erickson LD, Gale SD, Weiss J, El-Hajj ZW, Evans MK, Zonderman AB (2024) Infection burden, periodontal pathogens, and their interactive association with incident all-cause and Alzheimer’s disease dementia in a large national survey. Alzheimers Dement 20(9):6468–6485. 10.1002/alz.14141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bonvicini M, Travaglini S, Lelli D, Antonelli Incalzi R, Pedone C (2023) Is citicoline effective in preventing and slowing down dementia?-A systematic review and a meta-analysis. Nutrients 15(2):386. 10.3390/nu15020386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bucci LR (1994) A functional analytical technique for monitoring nutrient status and repletion. Part 3: clinical experience. Am Clin Lab 13:10–11 [PubMed] [Google Scholar]
  10. Chen P-H, Smith TJ, Wu J, Siesser PF, Bisnett BJ, Khan F, Hogue M, Soderblom E, Tang F, Marks JR, Major MB, Swarts BM, Boyce M, Chi J-T (2017) Glycosylation of KEAP1 links nutrient sensing to redox stress signaling. EMBO J 36:2233–2250. 10.15252/embj.201696113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chillon TS, Maares M, Demircan K, Hackler J, Sun Q, Heller RA, Diegmann J, Bachmann M, Moghaddam A, Haase H, Schomburg L (2022) Serum free zinc is associated with vaccination response to SARS-CoV-2. Front Immunol 13:906551. 10.3389/fimmu.2022.906551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goth CK, Goth CK, Petäjä-Repo UE, Rosenkilde MM (2020) G protein-coupled receptors in the sweet spot: glycosylation and other post-translational modifications. ACS Pharmacol Transl Sci 3(2):237–245. 10.1021/acsptsci.0c00016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Correas AG, Olaso-Gonzalez G, Roca M, Blanco-Gandía MC, Nascimento C, Lahoz A, Rodriguez-Arias M, Miñarro J, Gomez-Cabrera MC, Viña J (2024) Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP/PS1 mouse model of Alzheimer’s disease. Redox Biol 75:103242. 10.1016/j.redox.2024.103242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Devanarayan V, Doherty T, Charil A, Sachdev P, Ye Y, Murali LK, Llano DA, Zhou J, Reyderman L, Hampel H, Kramer LD, Dhadda S, Irizarry MC (2024) Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer’s disease. Alzheimers Dement 20(8):5617–5628. 10.1002/alz.14073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dong J, Pinto JM, Guo X, Alonso A, Tranah G, Cauley JA, Garcia M, Satterfield S, Huang X, Harris T, Mosley TH Jr, Chen H (2017) The prevalence of anosmia and associated factors among U.S. Black and White older adults. J Gerontol A Biol Sci Med Sci 72(8):1080–1086. 10.1093/gerona/glx081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Doty RL (2019) Psychophysical testing of smell and taste function. Handb Clin Neurol 164:229–246. 10.1016/B978-0-444-63855-7.00015-0 [DOI] [PubMed] [Google Scholar]
  17. Ekmekci OB, Donma O, Tunckale A (2003) Angiotensin-converting enzyme and metals in untreated essential hypertension. Biol Trace Elem Res 95(3):203–210. 10.1385/BTER:95:3:203 [DOI] [PubMed] [Google Scholar]
  18. Farooqi N, Rahman A, Ali Y, Ali K, Khan MEH, Jones DA, Abdelkarim M, Ullah F, Jalil F (2023) Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools. Open Life Sci 18(1):20220591. 10.1515/biol-2022-0591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fedotova IuO, Sultanov VS, Kuznetsova NN, Roshchin VI, Nikitina TV (2010) Effect of new polyprenol drug ropren on anxiety-depressive-like behavior in rats with experimental Alzheimer disease. Eksp Klin Farmakol 73(9):2–5 [PubMed] [Google Scholar]
  20. Fedotova J, Soultanov V, Nikitina T, Roschin V, Ordayn N (2012) Ropren(®) is a polyprenol preparation from coniferous plants that ameliorates cognitive deficiency in a rat model of beta-amyloid peptide-(25–35)-induced amnesia. Phytomedicine 19(5):451–456. 10.1016/j.phymed.2011.09.073 [DOI] [PubMed] [Google Scholar]
  21. Fedotova J, Soultanov V, Nikitina T, Roschin V, Ordyan N, Hritcu L (2016a) Ropren® treatment reverses anxiety-like behavior and monoamines levels in gonadectomized rat model of Alzheimer’s disease. Biomed Pharmacother 83:1444–1455. 10.1016/j.biopha.2016.08.065 [DOI] [PubMed] [Google Scholar]
  22. Fedotova J, Soultanov V, Nikitina T, Roschin V, Ordyan N, Hritcu L (2016b) Cognitive-enhancing activities of the polyprenol preparation Ropren® in gonadectomized β-amyloid (25–35) rat model of Alzheimer’s disease. Physiol Behav 157:55–62 [DOI] [PubMed] [Google Scholar]
  23. Fessel JP, Oldham WM (2018) Pyridine dinucleotides from molecules to man. Antioxid Redox Signal 28(3):180–212. 10.1089/ars.2017.7120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gao W, Guo L, Yang Y, Wang Y, Xia S, Gong H, Zhang B-K, Yan M (2022) Dissecting the crosstalk between Nrf2 and NF-κB response pathways in drug-induced toxicity. Front Cell Dev Biol 9:809952. 10.3389/fcell.2021.809952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Heller RA, Sun Q, Hackler J, Seelig J, Seibert L, Cherkezov A, Minich WB, Seemann P, Diegmann J, Pilz M, Bachmann M, Ranjbar A, Moghaddam A, Schomburg L (2021) Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol 38:101764. 10.1016/j.redox.2020.101764 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hoozemans JJM, Stieler J, van Haastert ES, Veerhuis R, Rozemuller AJM, Baas F, Eikelenboom P, Arendt T, Scheper W (2006) The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer’s disease pathogenesis. Exp Gerontol 41(4):380–386. 10.1016/j.exger.2006.01.013 [DOI] [PubMed] [Google Scholar]
  27. Kandel MB, Yamamoto S, Midorikawa R, Morise J, Wakazono Y, Oka S, Takamiya K (2018) N-glycosylation of the AMPA-type glutamate receptor regulates cell surface expression and tetramer formation affecting channel function. J Neurochem 147(6):730–747. 10.1111/jnc.14565 [DOI] [PubMed] [Google Scholar]
  28. Kang Y, Zhang Q, Xu S, Yu Y (2024) The alteration and role of glycoconjugates in Alzheimer’s disease. Front Aging Neurosci 16:1398641. 10.3389/fnagi.2024.1398641 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lazniewska J, Weiss N (2017) Glycosylation of voltage-gated calcium channels in health and disease. Biochim Biophys Acta Biomembr 1859(5):662–668. 10.1016/j.bbamem.2017.01.018 [DOI] [PubMed] [Google Scholar]
  30. Lennon JC, Aita SL, Bene VAD, Rhoads T, Resch ZJ, Eloi JM, Walker KA (2022) Black and white individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement 18(8):1461–1471. 10.1002/alz.12509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lichnerova K, Kaniakova M, Park SP, Skrenkova K, Wang YX, Petralia RS, Suh YH, Horak M (2015) Two N-glycosylation sites in the GluN1 subunit are essential for releasing N-methyl-d-aspartate (NMDA) receptors from the endoplasmic reticulum. J Biol Chem 290(30):18379–18390. 10.1074/jbc.M115.656546 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lin T, van Husen LS, Yu Y, Tjernberg LO, Schedin-Weiss S (2022) Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein. Glycobiology 32(6):506–517. 10.1093/glycob/cwac009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Liu RM (2022) Aging, cellular senescence, and Alzheimer’s disease. Int J Mol Sci 23(4):1989. 10.3390/ijms23041989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Liu AR, Ramakrishnan P (2021) Regulation of nuclear factor-kappaB function by O-GlcNAcylation in inflammation and cancer. Front Cell Dev Biol 9:751761. 10.3389/fcell.2021.751761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lopez-Lee C, Torres ERS, Carling G, Gan L (2024) Mechanisms of sex differences in Alzheimer’s disease. Neuron 112(8):1208–1221. 10.1016/j.neuron.2024.01.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lopresti AL (2020) Stress on micronutrient concentrations in the body: a review of the evidence. Adv Nutr 11(1):103–112. 10.1093/advances/nmz082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lyons CE, Bartolomucci A (2020) Stress and Alzheimer’s disease: a senescence link? Neurosci Biobehav Rev 115:285–298. 10.1016/j.neubiorev.2020.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Maginnis MS, Haley SA, Gee GV, Atwood WJ (2010) Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J Virol 84(19):9677–9684. 10.1128/JVI.00978-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mathew AT, Baidya ATK, Das B, Devi B, Kumar R (2023) N-glycosylation induced changes in tau protein dynamics reveal its role in tau misfolding and aggregation: a microsecond long molecular dynamics study. Proteins 91(2):147–160. 10.1002/prot.26417 [DOI] [PubMed] [Google Scholar]
  40. McMahon M, Swift SR, Hayes JD (2018) Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2. Toxicol Appl Pharmacol 360:45–57. 10.1016/j.taap.2018.09.033 [DOI] [PubMed] [Google Scholar]
  41. Miller MI, Pindwarawala M, Agosto MA (2024) Complex N-glycosylation of mGluR6 is required for trans-synaptic interaction with ELFN adhesion proteins. J Biol Chem 300(4):107119. 10.1016/j.jbc.2024.107119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Min C, Zheng M, Zhang X, Guo S, Kwon K-J, Shin CY, Kim H-S, Cheon SH, Kim K-M (2015) N-linked glycosylation on the N-terminus of the dopamine D2 and D3 receptors determines receptor association with specific microdomains in the plasma membrane. Biochim Biophys Acta 1853(1):41–51. 10.1016/j.bbamcr.2014.09.024 [DOI] [PubMed] [Google Scholar]
  43. Murray HC, Dieriks BV, Swanson MEV, Anekal PV, Turner C, Faull RLM, Belluscio L, Koretsky A, Curtis MA (2020) The unfolded protein response is activated in the olfactory system in Alzheimer’s disease. Acta Neuropathol Commun 8(1):109. 10.1186/s40478-020-00986-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nakajima M, Koga T, Sakai H, Yamanaka H, Fujiwara R, Yokoi T (2010) N-glycosylation plays a role in protein folding of human UGT1A9. Biochem Pharmacol 79(8):1165–1172. 10.1016/j.bcp.2009.11.020 [DOI] [PubMed] [Google Scholar]
  45. Neiers F, Jarriault D, Menetrier F, Faure P, Briand L, Heydel J-M (2021) The odorant metabolizing enzyme UGT2A1: immunolocalization and impact of the modulation of its activity on the olfactory response. PLoS ONE 16(3):e0249029. 10.1371/journal.pone.0249029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Neuhaus D (2022) Zinc finger structure determination by NMR: why zinc fingers can be a handful. Prog Nucl Magn Reson Spectrosc 130–131:62–105. 10.1016/j.pnmrs.2022.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Nishizaki T (2003) N-glycosylation sites on the nicotinic ACh receptor subunits regulate receptor channel desensitization and conductance. Brain Res Mol Brain Res 114(2):172–176. 10.1016/s0169-328x(03)00171-2 [DOI] [PubMed] [Google Scholar]
  48. Paprocka J, Jezela-Stanek A, Tylki-Szymańska A, Grunewald S (2021) Congenital disorders of glycosylation from a neurological perspective. Brain Sci 11(1):88. 10.3390/brainsci11010088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Patel V, Akimbekov NS, Grant WB, Dean C, Fang X, Razzaque MS (2024) Neuroprotective effects of magnesium: implications for neuroinflammation and cognitive decline. Front Endocrinol (Lausanne) 15:1406455. 10.3389/fendo.2024.1406455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Polsky LR, Rentscher KE, Carroll JE (2022) Stress-induced biological aging: a review and guide for research priorities. Brain Behav Immun 104:97–109. 10.1016/j.bbi.2022.05.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Portbury SD, Adlard PA (2017) Zinc signal in brain diseases. Int J Mol Sci 18(12):2506. 10.3390/ijms18122506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Rivers-Auty J, Tapia VS, White CS, Daniels MJD, Drinkall S, Kennedy PT, Spence HG, Yu S, Green JP, Hoyle C, Cook J, Bradley A, Mather AE, Peters R, Tzeng TC, Gordon MJ, Beattie JH, Brough D, Lawrence CB (2021) Zinc status alters Alzheimer’s disease progression through NLRP3-dependent inflammation. J Neurosci 41(13):3025–3038. 10.1523/JNEUROSCI.1980-20.2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Romero-Fernandez W, Borroto-Escuela DO, Alea MP, Garcia-Mesa Y, Garriga P (2011) Altered trafficking and unfolded protein response induction as a result of M3 muscarinic receptor impaired N-glycosylation. Glycobiology 21(12):1663–1672. 10.1093/glycob/cwr105 [DOI] [PubMed] [Google Scholar]
  54. Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G (1999) Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370(2):236–239. 10.1006/abbi.1999.1404 [DOI] [PubMed] [Google Scholar]
  55. Sakakihara Y, Volpe JJ (1985) Zn2+, not Ca2+, is the most effective cation for activation of dolichol kinase of mammalian brain. J Biol Chem 260(29):15413–15419. 10.1016/S0021-9258(17)36269-5 [PubMed] [Google Scholar]
  56. Schedin-Weiss S, Winblad B, Tjernberg LO (2014) The role of protein glycosylation in Alzheimer disease. FEBS J 281(1):46–62. 10.1111/febs.12590 [DOI] [PubMed] [Google Scholar]
  57. Schloss JV (2023) Nutritional deficiencies that may predispose to long COVID. Inflammopharmacology 31(2):573–583. 10.1007/s10787-023-01183-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Scott H, Panin VM (2014) The role of protein N-glycosylation in neural transmission. Glycobiology 24(5):407–417. 10.1093/glycob/cwu015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Shelton JF, Shastri AJ, Fletez-Brant K, Aslibekyan S, Auton A (2022) The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet 54(2):121–124. 10.1038/s41588-021-00986-w [DOI] [PubMed] [Google Scholar]
  60. Shridas P, Waechter CJ (2006) Human dolichol kinase, a polytopic endoplasmic reticulum membrane protein with a cytoplasmically oriented CTP-binding site. J Biol Chem 281(42):31696–31704. 10.1074/jbc.M604087200 [DOI] [PubMed] [Google Scholar]
  61. Sita G, Graziosi A, Corrieri C, Ghelli L, Angelini S, Cortelli P, Hrelia P, Morroni F (2023) The unfolded protein response in a murine model of Alzheimer’s disease: looking for predictors. Int J Mol Sci 24(22):16200. 10.3390/ijms242216200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Song Y, Qu Y, Mao C, Zhang R, Jiang D, Sun X (2024) Post-translational modifications of Keap1: the state of the art. Front Cell Dev Biol 11:1332049. 10.3389/fcell.2023.1332049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Soultanov V, Fedotova J, Nikitina T, Roschin V, Ordyan N, Hritcu L (2017) Antidepressant-like effect of Ropren® in β-amyloid-(25–35) rat model of Alzheimer’s disease with altered levels of androgens. Mol Neurobiol 54(4):2611–2621. 10.1007/s12035-016-9848-8 [DOI] [PubMed] [Google Scholar]
  64. Tong J, Okutani F, Murata Y, Taniguchi M, Namba T, Wang YJ, Kaba H (2017) Tunicamycin impairs olfactory learning and synaptic plasticity in the olfactory bulb. Neuroscience 344:371–379. 10.1016/j.neuroscience.2017.01.001 [DOI] [PubMed] [Google Scholar]
  65. Twarowski B, Herbet M (2023) Inflammatory processes in Alzheimer’s disease-pathomechanism, diagnosis and treatment: a review. Int J Mol Sci 24(7):6518. 10.3390/ijms24076518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Vali R, Shirvanian K, Farkhondeh T, Aschner M, Samini F, Samarghandian S (2025) A review study on the effect of zinc on oxidative stress-related neurological disorders. J Trace Elem Med Biol 88:127618. 10.1016/j.jtemb.2025.127618 [DOI] [PubMed] [Google Scholar]
  67. Wanamaker CP, Green WN (2005) N-linked glycosylation is required for nicotinic receptor assembly but not for subunit associations with calnexin. J Biol Chem 280(40):33800–33810. 10.1074/jbc.M501813200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Wilson MP, Kentache T, Althoff CR, Schulz C, de Bettignies G, Mateu Cabrera G, Cimbalistiene L, Burnyte B, Yoon G, Costain G, Vuillaumier-Barrot S, Cheillan D, Rymen D, Rychtarova L, Hansikova H, Bury M, Dewulf JP, Caligiore F, Jaeken J, Cantagrel V, Van Schaftingen E, Matthijs G, Foulquier F, Bommer GT (2024) A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis. Cell 187(14):3585-3601.e22. 10.1016/j.cell.2024.04.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Wolfe LS, Ng Ying Kin NM, Palo J, Bergeron C, Kotila M, Varonen S (1985) Dolichols are elevated in brain tissue from Alzheimer’s disease, but not in urinary sediment from Alzheimer’s disease and Down’s syndrome. Neurochem Pathol 3(4):213–221 [PubMed] [Google Scholar]
  70. Wu C-Y, Kupferschmid AC, Chen L, McManus AJ, Kivisäkk P, Galler JA, Schwab NA, DesRuisseaux LA, Williams VJ, Gerber J, Riley M, Young C, Guzmán-Vélez E, Dodge HH, Tanzi RE, Singer CM, Arnold SE (2025) Cognitive and Alzheimer’s disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimers Dement (n Y) 11(1):e70023. 10.1002/trc2.70023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wuerch E, Urgoiti GR, Yong VW (2023) The promise of niacin in neurology. Neurotherapeutics 20(4):1037–1054. 10.1007/s13311-023-01376-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Yang F, Deng X, Yu Y, Luo L, Chen X, Zheng J, Qiu Y, Xiao F, Xie X, Zhao Y, Guo J, Hu F, Zhang X, Ju Z, Zhou Y (2022) Association of human whole blood NAD+ contents with aging. Front Endocrinol (Lausanne) 13:829658. 10.3389/fendo.2022.829658 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yin SJ, Chou CF, Lai CL, Lee SL, Han CL (2003) Human class IV alcohol dehydrogenase: kinetic mechanism, functional roles and medical relevance. Chem Biol Interact 143–144:219–227. 10.1016/s0009-2797(02)00167-9 [DOI] [PubMed] [Google Scholar]
  74. Yoon D, Moon JH, Cho A, Boo H, Cha JS, Lee Y, Yoo J (2023) Structure-based insight on the mechanism of N-glycosylation inhibition by tunicamycin. Mol Cells 46(6):337–344. 10.14348/molcells.2023.0001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Zhang Y, Sun C, Ma L, Xiao G, Gu Y, Yu W (2024) O-GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2. Clin Transl Med 14(10):e70037. 10.1002/ctm2.70037 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

There is no original data to be shared in this manuscript.

Articles from Inflammopharmacology are provided here courtesy of Springer

RESOURCES